L. Andersen

发表

Anaemia of rheumatoid arthritis: serum erythropoietin concentrations and red cell distribution width in relation to iron status.

N. E. Hansen, H. Birgens, O. Nielsen, 1990, Annals of the rheumatic diseases.

Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? – Results from the randomized DAHANCA 5 and 7 trials

L. Specht, C. Grau, J. Overgaard, 2011, Acta oncologica.

Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2015, Scandinavian journal of rheumatology.

Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind

L. Hanson, M. Østergaard, K. Stengaard-Pedersen, 2017, Scandinavian journal of rheumatology.

Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial

J. K. Pedersen, T. Ellingsen, P. Junker, 2013, Annals of the rheumatic diseases.

Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression

K. Stengaard-Pedersen, J. K. Pedersen, T. Ellingsen, 2014, Scandinavian journal of rheumatology.

Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: relation to withdrawal and side effects.

J. Knudsen, T. M. Hansen, E. L. Hansen, 1997, The Journal of rheumatology.

Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?

M. Østergaard, J. Pødenphant, U. Tarp, 2007, Annals of the rheumatic diseases.

Serious Adverse Events Associated With Using Biological Agents To Treat Rheumatoid Diseases: Network Meta-Analysis From a National Guideline Panel

R. Christensen, B. Brock, S. Tarp, 2013 .

Surfactant protein D is decreased in rheumatoid arthritis

U. Holmskov, G. Hansen, K. Stengaard-Pedersen, 2008 .

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

A. Loft, I. Hansen, B. Glintborg, 2017, Annals of the rheumatic diseases.

FRI0607 Effect of Methotrexate and Intra-Articular Betamethasone with or Without Additional Cyclosporine on Magnetic Resonance Imaging (MRI)-Determined Inflammatory and Destructive Changes in Very Early Rheumatoid Arthritis – Results from a 24-Months' Randomised Double Blind Placebo Controlled Trial

K. Stengaard-Pedersen, J. K. Pedersen, T. Ellingsen, 2015 .

The case of tumour necrosis factor-α inhibitors in the treatment of rheumatoid arthritis

J. Sørensen, L. Andersen, 2012, PharmacoEconomics.

Circulating surfactant protein -D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritis

U. Holmskov, M. Østergaard, K. Stengaard-Pedersen, 2010, Arthritis research & therapy.

Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2012, Annals of the rheumatic diseases.

Uncoupling of Collagen II Metabolism in Newly Diagnosed, Untreated Rheumatoid Arthritis Is Linked to Inflammation and Antibodies Against Cyclic Citrullinated Peptides

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2010, The Journal of Rheumatology.

MRI Bone Oedema is the Strongest Predictor of Subsequent Radiographic Progression in Early RA: Results from a 2 Year Randomized Controlled Trial (CIMESTRA)

H. Thomsen, G. Hansen, M. Østergaard, 2007 .

ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors

A. Loft, P. Garnero, M. Østergaard, 2011, Annals of the rheumatic diseases.

Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiog

A. Loft, P. Garnero, M. Østergaard, 2011, Arthritis and rheumatism.

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

H. Thomsen, M. Østergaard, K. Stengaard-Pedersen, 2008, Annals of the rheumatic diseases.

Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor α inhibitors

A. Loft, M. Østergaard, K. Asmussen, 2009, Annals of the rheumatic diseases.

Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study

K. Stengaard-Pedersen, J. K. Pedersen, T. Ellingsen, 2007, Annals of the rheumatic diseases.

Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial

D. M. van der Heijde, T. M. Hansen, N. D. Peters, 1997, Annals of the rheumatic diseases.

To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

A. Loft, I. Hansen, F. Mehnert, 2018, Annals of the rheumatic diseases.

Mannose-Binding Lectin Gene Polymorphisms Are Associated with Disease Activity and Physical Disability in Untreated, Anti-Cyclic Citrullinated Peptide-Positive Patients with Early Rheumatoid Arthritis

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2009, The Journal of Rheumatology.

Serum transferrin receptor levels in anaemic patients with rheumatoid arthritis.

N. E. Hansen, O. Nielsen, T. M. Hansen, 1994, Scandinavian journal of clinical and laboratory investigation.

Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2010, Annals of the rheumatic diseases.

Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study.

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2006, Arthritis and rheumatism.

Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry

A. Loft, M. Østergaard, J. K. Pedersen, 2017, The Journal of Rheumatology.

Cartilage Oligomeric Matrix Protein Associates Differentially with Erosions and Synovitis and Has a Different Temporal Course in Cyclic Citrullinated Peptide Antibody (Anti-CCP)-positive versus Anti-CCP-negative Early Rheumatoid Arthritis

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2011, The Journal of Rheumatology.

One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept: – an Observational Study from the Danish Danbio Registry

A. Loft, I. Hansen, B. Glintborg, 2017 .

Low-field magnetic resonance imaging or combined ultrasonography and anti-cyclic citrullinated peptide antibody improve correct classification of individuals as established rheumatoid arthritis: results of a population-based, cross-sectional study

A. Voss, M. Østergaard, J. K. Pedersen, 2014, BMC Musculoskeletal Disorders.

Arthritis Antibody ( Anti-CCP )-positive versus Anti-CCP-negative Early Rheumatoid Synovitis and Has a Different Temporal Course in Cyclic Citrullinated Peptide Cartilage Oligomeric Matrix Protein Associates Differentially with Erosions and

A. Jacobsen, M. Østergaard, K. Stengaard-Pedersen, 2011 .

Different Cartilage Oligomeric Matrix Protein (COMP) Patterns in Untreated Anti-CCP Positive and Negative Rheumatoid Arthritis (RA)

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2009 .

[Danish recommendations on treatment of ankylosing spondylitis and spondyloarthritis based on multinational project initiative].

M. Ostergaard, O. Madsen, I. Sørensen, 2008, Ugeskrift for læger.

FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

B. Glintborg, M. Hetland, S. Chrysidis, 2017 .

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

A. Loft, I. Hansen, B. Glintborg, 2017, Annals of the rheumatic diseases.

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2008, Annals of the rheumatic diseases.

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2017, Scandinavian journal of rheumatology.

Limited e V ect of sulphasalazine treatment in reactive arthritis . A randomised double blind placebo controlled trial

T. M. Hansen, N. D. Peters, C. Egsmose, 1998 .

SAT0371 Hla-B27 Status Is Associated with tnfα Inhibitor Treatment Outcomes in Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis – Observational Cohort Study from The Nationwide Danbio Registry

M. Østergaard, J. K. Pedersen, L. Dreyer, 2016 .